Patrick J. McEnany - 30 Jan 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director, Chairman of Board of Directors
Signature
/s/ Patrick J. McEnany
Issuer symbol
CPRX
Transactions as of
30 Jan 2024
Net transactions value
$0
Form type
4
Filing time
31 Jan 2024, 17:01:28 UTC
Previous filing
03 Jan 2024
Next filing
19 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common Stock, par value $0.001 per share Options Exercise +26,333 +0.6% 4,411,589 30 Jan 2024 Direct F1
transaction CPRX Common Stock, par value $0.001 per share Options Exercise +116,667 +2.6% 4,528,256 30 Jan 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Restricted Stock Units Options Exercise $0 -26,333 -0.96% $0.000000 2,709,412 30 Jan 2024 Common Stock 26,333 Direct F1, F2, F3
transaction CPRX Restricted Stock Units Options Exercise $0 -116,667 -4.3% $0.000000 2,592,745 30 Jan 2024 Common Stock 116,667 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F2 Pursuant to a Separation Agreement between the Company and the Reporting Person, the Reporting Person's restricted stock units that would have vested within the fifteen month period following January 1, 2024 immediately vested.
F3 Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The shares were delivered on January 30, 2024.